Dr Shibal Bhartiya- Glaucoma Specialist in Gurgaon

Dr Shibal Bhartiya — Glaucoma Specialist in Gurgaon

Glaucoma surgery

 

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist  in Gurgaon, currently serving as Clinical Director of Ophthalmology at Marengo Asia Hospitals, Sector 56, Gurugram, and as Research Collaborator at Mayo Clinic, Jacksonville, Florida, USA.

Her clinical focus is glaucoma across its full spectrum — from early detection and borderline disease to complex surgery and second opinions for patients who need clarity on a difficult diagnosis. She also sees patients with neuro-ophthalmological conditions and ocular surface disease.

Dr Bhartiya trained at AIIMS New Delhi, completed a Clinical Research Fellowship in Glaucoma at the University of Geneva, Switzerland, and is currently enrolled for a Doctorate en Médecin at the University of Geneva. Over two decades of glaucoma specialty practice, international research collaboration, and editorial leadership in glaucoma have shaped an approach to care that is careful, long-term, and built around protecting vision — not just treating numbers.

At a Glance

🎓 Fellowship trained — University of Geneva, Switzerland & AIIMS New Delhi
🔬 Research Collaborator — Mayo Clinic, Jacksonville, USA (from 2024)
📚 200+ peer-reviewed publications · 20+ edited textbooks on glaucoma
🏆 Best Research Paper Awards — Asia Pacific Academy of Ophthalmology, Asia Pacific Glaucoma Congress, International Society of Glaucoma Surgery
🏥 Clinical Director, Ophthalmology — Marengo Asia Hospitals, Gurgaon

What I Treat

My practice is focused on patients with glaucoma at every stage — from those who have just been told they may be a glaucoma suspect, to those managing advanced disease after failed surgery. I also see a significant number of patients who come for a structured second opinion, from Gurgaon, NCT and all over India, often after an unclear diagnosis or conflicting advice from different doctors.

Conditions I see regularly: — Primary open-angle glaucoma and normal tension glaucoma — Angle closure glaucoma and angle closure suspects — Ocular hypertension and glaucoma suspects — Secondary glaucomas: steroid-induced, post-uveitic, post-traumatic, after retinal surgery or corneal transplant — Neovascular and complex refractory glaucoma — Neuro-ophthalmological conditions: optic neuropathy, unexplained visual field loss, optic neuritis, papilledema — Ocular surface disease and dry eye in the context of glaucoma treatment

If you are unsure whether your situation fits, the contact page has details for reaching my coordinator directly.

Training and Qualifications

Fellowship Training

Clinical Research Fellowship in Glaucoma, Clinique d’Ophtalmologie, Department of Clinical Neurosciences, Hôpitaux Universitaires de Genève, University of Geneva, Switzerland (2010–11).

Also enrolled: Doctorat en Médecin, University of Geneva.

Senior Clinical Research Associate, Cornea and Glaucoma Services, Dr R P Centre for Ophthalmic Sciences, AIIMS, New Delhi (2007–10).

MS Ophthalmology, Maulana Azad Medical College, New Delhi (2007–10).

Current Positions

Clinical Director, Ophthalmology, Marengo Asia Hospitals, Gurugram (July 2024 to date) Program

Director, Community Outreach & Wellness,  Marengo Asia Hospitals, Gurugram and Faridabad

Program Director, Marengo Asia International Institute of Neuro & Spine (Pan-India)

Research Collaborator, Mayo Clinic, Jacksonville, Florida, USA (September 2024 to date)

Academic and Editorial Leadership

Dr Bhartiya holds editorial positions at three international peer-reviewed journals:

 Editor-in-Chief, Clinical and Experimental Vision and Eye Research 

Editor-in-Chief, Ocular Research Journal

Executive Editor, Journal of Current Glaucoma Practice

She is a Member of the Associate Advisory Committee, International Society of Glaucoma Surgery, and serves on the Delhi Ophthalmic Society International Advisory Sub-Committee.

She has edited more than 20 textbooks in glaucoma and ophthalmology, and contributed chapters to more than 20 others. Her peer-reviewed research is indexed on PubMed and Google Scholar.

Awards and Recognition

Best Paper, Glaucoma Session — APAO, Hyderabad (Continuous IOP Monitoring in Glaucoma)

Best Paper, Glaucoma Session and Top Nine Most Influential Papers — Asia Pacific Glaucoma Congress, Bali 2012 (Diurnal IOP Fluctuation in Angle Closure)

 Multiple best paper recognitions at International Society for Glaucoma Surgery congresses

Global Outreach and Community Work

Beyond clinical practice, Dr Bhartiya has led glaucoma screening and surgical programmes in underserved communities across three continents.

In Egypt, she led a humanitarian mission to Kom Ombo General Hospital, Aswan, conducting screening for over 5,000 patients including children, and provided both medical and surgical management of advanced glaucomas in North Africa. She has also delivered skill-transfer sessions in advanced glaucoma care for doctors, residents, and optometrists in Aswan.

In Switzerland, she designed and executed hospital-based and community glaucoma screening protocols in Geneva and Troinnex, and led screening of United Nations personnel as part of World Glaucoma Week.

In India, she is an active contributor to the Motiabind Mukti Abhiyan cataract outreach programme, has led eye camps in Sirsa (Haryana), and runs school health initiatives and government employee screening programmes in Gurugram.

She is also the founder of Vision Unlimited, a not-for-profit organisation currently running six learning centres in urban Gurugram, serving over 1,200 children with education, nutrition, and healthcare support.

As part of the Eye on the Future program, Vision Unlimited under the guidance of Dr Bhartiya has screened more than 15000 school children; and 5000 elders from underserved areas for refractive errors, and other ocular morbidities. 

Research

Active clinical research collaborations span glaucoma medication adherence, quality of life, IOP monitoring, community-based screening, and surgical outcomes. Dr Bhartiya collaborates with glaucoma specialists across more than 20 countries.

Current trials include work on 24-hour ambulatory IOP monitoring, selective laser trabeculoplasty as primary therapy, tear film osmolarity in glaucoma patients, and quantitative versus qualitative IOP control, as well as metabolic determinants of glaucoma.

Full publication list: PubMed · Google Scholar · Publications page

Book an Appointment

For appointments at Marengo Asia Hospitals, Sector 56, Gurugram, please contact my coordinator at +91 88826 38735.

If you are seeking a structured glaucoma second opinion, you may also use the second opinion form to submit your reports in advance of your consultation.

As a fellowship-trained glaucoma specialist (from University of Geneva, Switzerland, and AIIMS, New Delhi) in Gurgaon, Dr Shibal Bhartiya works with patients across the full spectrum of glaucoma—from suspects and early disease to advanced and complex cases. Her approach emphasises risk stratification, longitudinal follow-up, and calm decision-making, helping patients avoid late surprises and unnecessary interventions.

Patients often seek her care for early glaucoma diagnosis, second opinions, treatment planning, and long-term glaucoma management (medical, glaucoma lasers and glaucoma surgery including MIGS, trabeculectomy and complex tubes and shunts), especially when clarity is needed in uncertain, complex, or borderline cases.

Academic Qualifications:

  • 2010-11 – Clinical Research Fellowship, Glaucoma, University of Geneva, Switzerland
  • 2007-10 – MS (Ophthalmology), Maulana Azad Medical College, New Delhi, India
    1993-99 – M.B.B.S, Maulana Azad Medical College, New Delhi
  • 2000-03 – Clinical Research Associateship, Cornea and Glaucoma, Dr R P Centre for Ophthalmic Sciences, AIIMS, New Delhi, India
  • Doctorate en Medicin, University of Geneva, Switzerland (Currently enrolled)

Experience details:

  • July 2024 to date- Clinical Director, Ophthalmology (MAH, Gurgaon); Program Director, Community Outreach & Wellness (MAH, Gurgaon and Faridabad)
    Program Director, Marengo Asia International Institute of Neuro & Spine (Pan-India)
  • Sept 2024 to date– Research collaborator, Mayo Clinic, Jacksonville, USA
  • 2019 to Date: Member, Associate Advisory Board, International Society of Glaucoma Surgery
  • 2012-July 2024- Director, Additional Director, Sr. Consultant, Consultant – Ophthalmology, Fortis Memorial Research Institute, India

Additional Role

  • Sept 2024 – till date- Research collaborator, Mayo Clinic, Jacksonville, USA
  • August 2015-October 2015- Consultant, Cantahealth, Healthcare Practice, Eliglobal, Charlotte, North Carolina, USA. (Training and development of AI platforms and interfaces in Ophthalmology)
  • Oct 2015- April 2017- Clinical Director, Medflow, Eye Care Leaders (Eliglobal), Charlotte, North Carolina, USA. (Training and development of AI platforms and CDSS interfaces in Ophthalmology)
  • Sept 2012 to Aug 2015 – Consultant, Glaucoma and Preventive Health Services, Department of Ophthalmology, Fortis Memorial Research Institute, Gurgaon, Haryana
  • Sept 2011 to Aug 2012 – Consultant Glaucoma and In charge of Academics and Research, Eye 7 Group of Hospitals, New Delhi
  • Jul 2010 to Jul 2011 – Senior Scientific- Clinical Research Fellow, Glaucoma Sector, Clinique d’ ophthalmologie, Department of Clinical Neurosciences, Glaucoma Sector, Hopitaux Universitaires de Geneve, Switzerland. (Responsibilities including teaching resident doctors and glaucoma fellows)
  • Mar 2007 to Mar 2010 – Senior Research Associate, Dr R P Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, AIIMS, New Delhi. (Responsibilities including teaching resident doctors)
  • Sept 2003 to Sept 2006 – Senior Registrar, University College of Medical Sciences, and associated Guru Teg Bahadur Hospital, New Delhi. (Responsibilities including teaching resident doctors)

Languages known:

English, Hindi, Urdu, French

Academic, Organisational and Leadership positions:

  • 2024 – Present- Editor in Chief, Ocular Research Journal
  • 2017-to date: Founder, Vision Unlimited, Not for Profit Organization for social responsibility https://vision-unlimited.org/
  • 2019-to date – Editor in Chief –Clinical and Experimental Vision and Eye Research https://www.cleverjournal.org/ https://www.cleverjournal.org/editorial-team/
  • 2016-to date –  Executive Editor – Journal of Current Glaucoma Practice https://www.jocgp.com/journalDetails/JOCGP https://www.jocgp.com/editorialBoard/JOCGP
  • 2019 to Date: Member, Associate Advisory Board, International Society of Glaucoma Surgery
  • 2024 to Date- Member, Program Committee, Bal Raksha Bharat, Save the Children, India
  • 2016 to 2021: Executive Editor-DOS Times
  • 2016-till date: Founder Member, Khem, LGBTQ Rights
  • 2009 to 2016 – Managing Editor – Journal of Current Glaucoma Practice
  • 2023 to date- Member, Delhi Ophthalmic Society International advisory sub-committee
  • 2011 – Founding Secretary – Shamms Ed Deen Alcon Glaucoma Fund, University of Geneva, Switzerland
  • 2013 – Member Scientific Committee – World Glaucoma Congress
  • 2012 – Member Scientific Committee – International Society for Glaucoma Surgery
  • 2010 – Member, Organising Committee – International Society for Glaucoma Surgery
  • Apr 2008 to Dec 2009 – Associate Editor – Delhi Journal of Ophthalmology
  • 2008 – Co-Editor – Proceedings of the Strabismic Panorama
  • 2001 to 2003 – Assistant Editor – Indian Journal of Strabismology and Pediatric Ophthalmology
  • 2007 to 2008 – Deputy Editor – Delhi Journal of Ophthalmology
  • Reviewer for several journals worldwide.

Professional Memberships:

  • International Society of Glaucoma Surgery
  • Glaucoma Society of India
  • Strabismological Society of India
  • All India Ophthalmological Society
  • Delhi Ophthalmological Society
  • Haryana Ophthalmological Society
  • Gurugram Ophthalmological Society
  • American Academy of Ophthalmology
  • Association for Research and Vision in Ophthalmology

Community Ophthalmology Programmes:

  • Responsible for design of skill transfer sessions in glaucoma care, and for screening manuals for glaucoma in Africa and the Middle East. Projected collaboration in execution
  • Skill transfer sessions in advanced glaucoma care in Aswan, Egypt for doctors, residents and optometrists
  • Humanitarian mission to Kom Ombo General Hospital, Aswan, Egypt. Screening program for over 5000 patients, including children for glaucoma in Kom Ombo General Hospital, Aswan, Egypt
  • Management, both medical and surgical, of advanced glaucomas in North Africa
  • Screening for glaucoma and designing and execution of protocols and SOPs for hospital based and community outreach programs, Geneva and Troinnex, Switzerland
  • Screening of UN personnel for glaucoma in an outreach exercise as part of World Glaucoma Week in Geneva, Switzerland
  • Actively involved in the Motiabind Mukti Abhiyan, an outreach program for cataract management in India
  • Execution of eye camps in Sirsa, Haryana, as part of a community sponsored initiative
  • School health and eye care initiatives, Gurugram, Haryana
  • Screening programs for police officers and government officials in Gurugram, Haryana
  • Screening programs for community based screening in Pilibhit, UP and Mewat, Haryana

Design of clinical trials:

  • Population based survey of anterior chamber configuration in North African populations
  • Histochemical correlates of chronic glaucoma medication use on trabecular meshwork and ocular surface
  • Persistency, adherence and compliance to glaucoma medications
  • Selective laser trabeculoplasty as primary therapy in an African population: An efficacy and economics perspective
  • Tear film osmolarity studies in patients on glaucoma therapy
  • Comparative evaluation of sclerothalamotomy ab interno combined with phacoemulsification versus phacoemulsification alone in POAG patients
  • Quantitative versus qualitative control of IOP: A risk benefit analysis
  • 24 hour ambulatory IOP monitoring in angle closure glaucoma
  • Effect of increased intraocular pressure on retinal ganglion cells in chick embryos

Awards

  • Continuous IOP Monitoring In Glaucoma Patients Treated With Tafluprost. Shibal Bhartiya, Aref A, Shaarawy T. APAO, Hyderabad, India. Best Paper, Glaucoma session
  • Diurnal Intraocular Pressure Fluctuation in Eyes with Angle Closure. Shibal Bhartiya, Ichhpujani P. Asia Pacific Glaucoma Congress 2012, Bali, Indonesia. Best paper glaucoma session, Top nine most influential papers of the congress
  • Harry Potter and the Ophthalmologists Nemesis: Shibal B., S Khokhar, IV International Congress of Glaucoma Surgery, April 2009, Geneva. Best Poster
  • Comparative evaluation of time domain and spectral domain optical coherence tomography in retinal nerve fiber layer thickness measurements. S.Bhartiya, Jayaprakash V, T Dada, A Panda. DOS Annual Conference, March 2009.Best free paper, glaucoma session.
  • Evaluation of levo-dopa as a therapeutic adjunct to conventional occlusion in amblyopia; Kamlesh, Dadeya S, Shibal F. DOS Midcon, 2001 .Best free paper, squint session.
  • Asia ARVO Young Scientists Travel Grant for the year 2008
  • CSIR Young Scientists Travel Grant for the year 2003,2009
  • World Glaucoma Association Young Scientists Travel Grant for the year 2009, 2013Ju

CV

Published Articles